1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BLUEPRINT MEDICINES CORP
Blueprint Medicines Corp XNAS: BPMC

Blueprint Medicines Corp Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living wit...

Read More
129.46 0.18 (0.14%)
Near 52W High of $129.65
2.9M
XNAS Volume

XNAS 17 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Blueprint Medicines Corp is on 01 Aug 2025 for the purpose of Blueprint Medicines Corp Second Quarter Earnings Results for 2025 See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Expensive Valuation
6.2 / 100
Momentum Score
Technically Neutral
58.0 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
130
1Yr Price target upside is 1%
7 analysts

18

S

2

W

0

O

3

T

SWOT Analysis

Blueprint Medicines Corp Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..